Athermal Versus Ultrasonic Nerve‑Sparing Laparoscopic Radical Prostatectomy: A Comparison of Functional and Oncological Outcomes – Beyond the Abstract 

Radical prostatectomy (RP) remains the gold standard treatment for organ-confined prostate cancer. Nonetheless, it may impact on the quality of life (QoL),1 as many men complain about sexual dysfunction and urinary incontinence.2 There are several variables impacting on QoL after surgery, so there is a large variability in reported functional outcomes; i.e., the impairment of […]

Exelixis Announces Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for CABOMETYX® (cabozantinib) in Combination With Opdivo® (nivolumab) for Advanced Renal Cell Carcinoma

Submission based on the phase 3 pivotal CheckMate -9ER trial, which met its primary endpoint of significantly improving progression-free survival and secondary endpoints of overall survival and objective response rate San Francisco, CA (UroToday.com) — Exelixis, Inc. announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) […]

Comparative study of the influence of 3D versus 2D urological laparoscopy on surgeons’ surgical performance and ergonomics: A systematic review and meta-analysis.

The objective of this study is to compare the use of three-dimensional (3D) vision systems with traditional two-dimensional (2D) systems in laparoscopic urological surgery, analyzing the benefits, limitations and impact of introducing this medical technology with regard to surgical performance and the surgeon’s ergonomics.

X